Best Life Sciences Companies in Toulouse, France
The 33 best Life Sciences companies in Toulouse, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: GamaMabs.
Our analysis of 50 Life Sciences companies
$3.3b in tracked funding; 62% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Toulouse
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GamaMabs Developer of engineered monoclonal antibodies for the treatment of ovarian cancer | $22M | 130 mo ago | Series B | 7 | — | — | — | — |
| 2 | Flash Therapeutics Provider of gene-based therapeutics for multiple disorders | $12M | 63 mo ago | Series A | 49 | — | — | 37 patents RNA/genome‑editing delivery vectors and apelin‑based therapies for lymphedema treatment | — |
| 3 | Ixaltis Drugs for the treatment of stress urinary incontinence. | $9M | 125 mo ago | Series A | 2 | Roberto Gradnik CEO | — | 2 patents Pharmaceutical piperidine compounds for treating urinary incontinence | — |
| 4 | BOYDSense Developer of a breath-based diabetes monitor | $8M | 30 mo ago | Series A | 9 | — | — | — | — |
| 5 | X-Pressure Provider of a medical device to measure cerebrospinal fluid pressure to diagnose brain diseases | $5M | 39 mo ago | Series A | 3 | Eric Schmidt Co-Founder | — | 2 patents Electro‑medical pressure measurement devices and associated sensor kits | — |
| 6 | REEV Developer of AI-powered exoskeletons and gait analysis tools for mobility recovery. 48Growth top 35%Talent top 38%Funding top 40%AI top 45% All 8 signals ▾Growthtop 35% Talenttop 38% Fundingtop 40% AItop 45% Producttop 46% Techbottom 47% Globalbottom 43% Marketbottom 26% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 48/100 | $3M | 20 mo ago | Series B | 16 | Robin Temporelli CTO & Co-Founder - Technical and operational manager for the development of electromedical products | WordPressMySQLPHP+29 | — | — |
| 7 | Kyanos Developer of microalgae-based supplements for multiple health ailments | $3M | 66 mo ago | Series A | 16 | Vinh Ly Founder & CEO | — | — | — |
| 8 | Ambiotis Provider of preclinical developmental services in inflammatory assays, mediators, and lipid analysis | $1M | 102 mo ago | Funding Raised | 11 | Marc Dubourdeau Founder & CEO | JoomlaAwesompletePHP+9 | — | — |
| 9 | Telegrafik Provider of IoT based solution for elderly care | $1M | 84 mo ago | Seed | 17 | Carole Garat Founder & CEO | WordPressMySQLPHP+17 | — | — |
| 10 | Univercell Biosolutions Platform for human endocrine cell line generation | $711K | 117 mo ago | Deadpooled | 11 | Guillaume Costecalde Chairman & CEO | — | 7 patents Human beta-cell lines for diabetes diagnostics and primate cardiovascular progenitor cells for drug testing | — |
| 11 | Dexstr Digital clinical data management tool for providers | $336K | 133 mo ago | Deadpooled | 8 | — | — | — | — |
| 12 | ICELLTIS Provider of human cells for research purposes | $110K | 123 mo ago | Funding Raised | — | Veronique Santran Owner | — | — | — |
Top 12 Life Sciences companies in Toulouse
#1
Series B · Toulouse, Occitanie · founded 2021 · 16 employees$3.2Mraised▾
{}
- Feb 2025Series B$9.2M
- Sep 2023Series A$3.2M
- Jan 2023Seed$20K
#2
Series A · Toulouse, Occitanie · founded 2015 · 9 employees$7.6Mraised▾
Developer of a breath-based diabetes monitor. The Lassie breath analyzer is a non-invasive device for measuring critical biomarkers from exhaled breath and detects glucose levels. This device also detects and monitors other diseases such as cancer, obesity, asthma, and more.
- Apr 2024Series A$7.5M
- Grant (prize money)$61.3K
#3
Series A · Toulouse, Occitanie · founded 2021 · 3 employees$4.9Mraised▾
Provider of a medical device to measure cerebrospinal fluid pressure to diagnose brain diseases. It offers a sensor to the end of the lumbar puncture needle which meassure opening pressure using mobile application and AI-based algorithms.
- Jul 2023Series A$4.9M
#4
Series A · Toulouse, Occitanie · founded 2005 · 49 employees$11.5Mraised▾
Provider of gene-based therapeutics for multiple disorders. The company is developing gene and cell-based therapies for IPEX syndrome and lymphedema. The company has a lentiviral platform, transient RNA delivery, CAR-T cancer immunotherapy, and other gene-editing technology.
- Jul 2021Series A$4.7M
- May 2018Series A$3.9M
- Aug 2017Grant (prize money)$59.7K
- 2017Series A—
#5
Series B · Toulouse, Occitanie · founded 2013 · 7 employees$22.2Mraised▾
GamaMabs Pharma develops monoclonal antibodies for cancer treatment. Its lead candidate, monoclonal antibody (mAb) 3C23K which targets Anti-Müllerian Human Receptor II (AMHRII), specific target in ovarian cancer. The company has rights on a glycoengineering technology (EMABling) developed at LFB Biotechnologies (France) which enhances the efficacy of mAbs through the activation of immune cells.
- Dec 2015Series B$16.5M
- Mar 2014Series A$1.5M
- Sep 2013Series A$4.2M
#6
Series A · Toulouse, Occitanie · founded 2016 · 16 employees$3.1Mraised▾
Developer of microalgae-based supplements for multiple health ailments. The company leverages research and technology and develops microalgae-based dietary supplements for immune health, sports, energy, focus, and skincare.
- May 2021Series A$3.1M
- Oct 2019Grant (prize money)$55.6K
- May 2019Grant (prize money)$56K
#7
Series A · Toulouse, Occitanie · founded 2012 · 2 employees$8.9Mraised▾
Ixaltis is developing therapeutics for the treatment of genito-urinary diseases including stress urinary incontinence. Its lead candidate includes IXA-001 (Litoxetine) for the treatment of stress urinary incontinence which Ixaltis licensed from Sanofi and is in Phase1/2 clinical trials.
- May 2016Series A$8.9M
#8
Funding Raised · Toulouse, Occitanie · founded 2007 · 11 employees$1.5Mraised▾
Ambiotis is specialized in inflammation and its resolution. They are offering inflammatory assays, mediators and lipid analysis by mass spectrometry. The company has developed a step by step approach to anti-inflammation resolution strategies which includes in vitro screening of drug potential and in vivo proof-of-concept (disease models). The in vitro models include whole blood, monocytes, dendritic cells, macrophages, keratinocytes, fibroblasts, melanocytes, and others. In vivo models include respiratory disease, allergy, intestinal bowel disease, obesity, fibrosis, etc. They also provide analytical services including lipid analysis, gene expression, etc. The company also specializes in the valorization of nutritional and dermatological products.
- May 2018Grant (prize money)$747.3K
- Jan 2018Grant (prize money)$747.3K
#9
Seed · Toulouse, Occitanie · founded 2013 · 17 employees$1.1Mraised▾
Telegrafik provides an IoT-based solution for elderly care. Offers Otono-me which is an intelligent software platform that provides activity monitoring and alerting services based on data from sensors located in homes or residences. Features real-time activity analysis, real-time alerts, predictive statistics, activity dashboards and more.
- Oct 2019Seed$1.1M
#10
Deadpooled · Toulouse, Occitanie · founded 2010 · 11 employees$711.1Kraised▾
Universal Biosolutions develops a platform for the generation of human endocrine cell lines. It has three cell lines EndoC BH1, EndoC BH2 and EndoC BH3, all of which are immortalized or conditionally-immortalized cell lines that closely mimic human pancreatic beta cells for the production of insulin. Applications include drug discovery, toxicity and drug development, replacement cell therapy for chronic diseases, and diagnostics.
- Jan 2017Grant (prize money)$53.5K
- Jan 2017Grant (prize money)$601.8K
- Aug 2016Grant (prize money)$55.8K
#11
Deadpooled · Toulouse, Occitanie · founded 2014 · 8 employees$335.6Kraised▾
Digital clinical data management tool for providers
- Sep 2015Seed$335.6K
#12
Funding Raised · Toulouse, Occitanie · founded 2008$110.3Kraised▾
Provider of human cells for research purposes. The company specializes in providing products for research, including human cells, 3D models of tumors, and biomaterials. It offer primary cells from human adults, specific tissues, osteoblasts, chondroblasts, cancerous cells, and stem cells from human adults.
- Jul 2016Grant (prize money)$55.8K
- Feb 2016Grant (prize money)$54.5K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Toulouse is moving
A read on the academic research around Biotechnology in Toulouse — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 47 papers.
- Université Fédérale de Toulouse Midi-Pyrénées19
- Université Toulouse III - Paul Sabatier10
- École Nationale Vétérinaire de Toulouse9
- Institut National Polytechnique de Toulouse8
- Centre de Recherche en Cancérologie de Toulouse6
- Interleukin 333
- Cytokine3
- Cell biology2
- Molecular biology2
- Cathepsin G1
- Paracellular transport2
- Selection (genetic algorithm)2
- Livestock1
- Ruminant1
- Nutraceutical1
- Population3
- Phenome1
- Genomics1
- Population genetics1
- Genome1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.